1. PI3K/AKT/mTOR pathway plays a major pathogenetic role in glycogen accumulation and tumor development in renal distal tubules of rats and men
   Silvia Ribback et al, 2015, Oncotarget CrossRef
2. The crosstalk between sonodynamic therapy and autophagy in cancer
   Yujie Zhang et al, 2022, Frontiers in Pharmacology CrossRef
3. Blocking Autophagic Flux Enhances Matrine-Induced Apoptosis in Human Hepatoma Cells
   Li Wang et al, 2013, International Journal of Molecular Sciences CrossRef
4. Induction of autophagy by PI3K/MTOR and PI3K/MTOR/BRD4 inhibitors suppresses HIV-1 replication
   Grant R. Campbell et al, 2018, Journal of Biological Chemistry CrossRef
5. Silybin suppresses cell proliferation and induces apoptosis of multiple myeloma cells via the PI3K/Akt/mTOR signaling pathway
   NAN FENG et al, 2016, Molecular Medicine Reports CrossRef
6. MiR-223 modulates hepatocellular carcinoma cell proliferation through promoting apoptosis via the Rab1-mediated mTOR activation
   Zheng Dong et al, 2017, Biochemical and Biophysical Research Communications CrossRef
7. Targeting the vasculature in hepatocellular carcinoma treatment: Starving versus normalizing blood supply
   Ken Liu et al, 2017, Clinical and Translational Gastroenterology CrossRef
8. NVP-BEZ235, a dual PI3K-mTOR inhibitor, suppresses the growth of FaDu hypopharyngeal squamous cell carcinoma and has a synergistic effect with Cisplatin
   Cheng-Ming Hsu et al, 2018, Cell Death Discovery CrossRef
9. GSK-3β inhibits autophagy and enhances radiosensitivity in non-small cell lung cancer
   Jialin Ren et al, 2018, Diagnostic Pathology CrossRef
10. The synergistic anti-proliferative effect of the combination of diosmin and BEZ-235 (dactolisib) on the HCT-116 colorectal cancer cell line occurs through inhibition of the PI3K/Akt/mTOR/NF-κB axis
    Maged. W. Helmy et al, 2020, Molecular Biology Reports CrossRef
11. Autophagy Plays a Dual Role in Drug Resistance
    Sameer Ullah Khan et al, 2024, Drug Resistance in Cancer: Mechanisms and Strategies CrossRef
12. Increased expression of PDIA3 and its association with cancer cell proliferation and poor prognosis in hepatocellular carcinoma
    Hideyuki Takata et al, 2016, Oncology Letters CrossRef
13. Role of autophagy in cholangiocarcinoma: Pathophysiology and implications for therapy
    Elisabetta Ninfole et al, 2021, World Journal of Clinical Cases CrossRef
14. Combination Therapy with a PI3K/mTOR Dual Inhibitor and Chloroquine Enhances Synergistic Apoptotic Cell Death in Epstein–Barr Virus-Infected Gastric Cancer Cells
    Mi-Young Kim et al, 2019, Molecules and Cells CrossRef
15. Salvianolic acid B inhibits RAW264.7 cell polarization towards the M1 phenotype by inhibiting NF-κB and Akt/mTOR pathway activation
    Tao Zou et al, 2022, Scientific Reports CrossRef
16. Low-level laser irradiation at a high power intensity increased human endothelial cell exosome secretion via Wnt signaling
    Hesam Saghaei Bagheri et al, 2018, Lasers in Medical Science CrossRef
17. ANXA2 (annexin A2) is crucial to ATG7-mediated autophagy, leading to tumor aggressiveness in triple-negative breast cancer cells
    Minsoo Koh et al, 2024, Autophagy CrossRef
18. Hepatocellular carcinoma (HCC): the most promising therapeutic targets in the preclinical arena based on tumor biology characteristics
    Haichuan Wang et al, 2021, Expert Opinion on Therapeutic Targets CrossRef
19. Antitumor effects and mechanisms of 1,25(OH)2D3 in the Pfeiffer diffuse large B lymphoma cell line
    Jing Han et al, 2019, Molecular Medicine Reports CrossRef
20. The anticancer activities of Vernonia amygdalina Delile. Leaves on 4T1 breast cancer cells through phosphoinositide 3-kinase (PI3K) pathway
    Poppy Anjelisa Zaitun Hasibuan et al, 2020, Heliyon CrossRef
21. Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles
    Azar Gharoonpour et al, 2023, Frontiers in Oncology CrossRef
22. 4″-Alkyl EGCG Derivatives Induce Cytoprotective Autophagy Response by Inhibiting EGFR in Glioblastoma Cells
    Satyam Singh et al, 2024, ACS Omega CrossRef
23. miR‑16‑2‑3p inhibits cell proliferation and migration and induces apoptosis by targeting PDPK1 in�maxillary primordium mesenchymal cells
    Tao Han et al, 2019, International Journal of Molecular Medicine CrossRef
24. Knockdown of STMN1 enhances osteosarcoma cell chemosensitivity through inhibition of autophagy
    Zili Wang et al, 2017, Oncology Letters CrossRef
25. Therapeutic Potential of Autophagy in Glioblastoma Treatment With Phosphoinositide 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin Signaling Pathway Inhibitors
    Qin Xia et al, 2020, Frontiers in Oncology CrossRef
26. The Role of PI3K Signaling Pathway in Intestinal Tumorigenesis
    Jennifer W. Harris et al, 2015, Intestinal Tumorigenesis CrossRef
27. PI3K/PTEN signaling in liver diseases
    Alfredo Fort et al, 2015, Signaling Pathways in Liver Diseases CrossRef
28. COL1A1: A potential therapeutic target for colorectal cancer expressing wild-type or mutant KRAS
    Zheying Zhang et al, 2018, International Journal of Oncology CrossRef
29. Endoplasmic reticulum stress and protein degradation in chronic liver disease
    Si-Wei Xia et al, 2020, Pharmacological Research CrossRef
30. The Synergistic Anti-Cancer Effects of NVP-BEZ235 and Regorafenib in Hepatocellular Carcinoma
    Cheng-Chan Yu et al, 2020, Molecules CrossRef
31. Autophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer Therapy
    Ying-Ying Li et al, 2017, International Journal of Molecular Sciences CrossRef
32. Autophagy: Dual Response in the Development of Hepatocellular Carcinoma
    Hamza O. Yazdani et al, 2019, Cells CrossRef
33. Inhibiting Autophagy
    Michael T. Lotze et al, 2013, The Cancer Journal CrossRef
34. Identification of 7-(4′-Cyanophenyl)indoline-1-benzenesulfonamide as a mitotic inhibitor to induce apoptotic cell death and inhibit autophagy in human colorectal cancer cells
    Tung-Yun Wu et al, 2017, Scientific Reports CrossRef
35. Discovery of benzenesulfonamide derivatives as potent PI3K/mTOR dual inhibitors with in vivo efficacies against hepatocellular carcinoma
    Ying Chen et al, 2016, Bioorganic & Medicinal Chemistry CrossRef
36. A review on the potential risks and mechanisms of heavy metal exposure to Chronic Obstructive Pulmonary Disease
    Shuxia Yu et al, 2023, Biochemical and Biophysical Research Communications CrossRef
37. Molecular therapy of colorectal cancer: Progress and future directions
    Wenhao Weng et al, 2015, International Journal of Cancer CrossRef
38. XIAP inhibitor embelin induces autophagic and apoptotic cell death in human oral squamous cell carcinoma cells
    You‐Jin Lee et al, 2017, Environmental Toxicology CrossRef
39. Targeting autophagy to overcome drug resistance: further developments
    Haocai Chang et al, 2020, Journal of Hematology & Oncology CrossRef
40. Crosstalk between Apoptosis and Autophagy: Molecular Mechanisms and Therapeutic Strategies in Cancer
    Abdelouahid El-Khattouti et al, 2013, Journal of Cell Death CrossRef
41. Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges
    Mahshid Deldar Abad Paskeh et al, 2023, Pharmacological Research CrossRef
42. Diindolylmethane Inhibits Cadmium-Induced Autophagic Cell Death via Regulation of Oxidative Stress in HEL299 Human Lung Fibroblasts
    Yeon-Seop Jung et al, 2022, Molecules CrossRef
43. Autophagy prevents doxorubicin-induced apoptosis in osteosarcoma
    DONGXU ZHAO et al, 2014, Molecular Medicine Reports CrossRef
44. Autophagy modulators for the treatment of oral and esophageal squamous cell carcinomas
    Tuhina Khan et al, 2020, Medicinal Research Reviews CrossRef
45. Molecular Mechanisms Underlying Autophagy-Mediated Treatment Resistance in Cancer
    Cally J. Ho et al, 2019, Cancers CrossRef
46. Salvianolic acid B improves autophagic dysfunction and decreases the apoptosis of cholesterol crystal‑induced macrophages via inhibiting the Akt/mTOR signaling pathway
    Mengqi Sun et al, 2021, Molecular Medicine Reports CrossRef
47. Simultaneous activation and blockade of autophagy to fight hepatocellular carcinoma
    Hala Shalhoub et al, 2024, Autophagy Reports CrossRef
48. Construction of an Immunogenic Cell Death-Related Gene Signature and Genetic Subtypes for Predicting Prognosis, Immune Microenvironments, and Drug Sensitivity in Hepatocellular Carcinoma
    Shuo Li et al, 2024, Journal of Inflammation Research CrossRef
49. NVP-BEZ235 Attenuated Cell Proliferation and Migration in the Squamous Cell Carcinoma of Oral Cavities and p70S6K Inhibition Mimics its Effect
    Cheng-Ming Hsu et al, 2018, International Journal of Molecular Sciences CrossRef
50. Emerging strategies to effectively target autophagy in cancer
    V W Rebecca et al, 2016, Oncogene CrossRef
51. PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways
    L Chang et al, 2014, Cell Death & Disease CrossRef
52. Untangling knots between autophagic targets and candidate drugs, in cancer therapy
    Tao Xie et al, 2015, Cell Proliferation CrossRef